Home Nano Research Article
PDF (861.5 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript
Erratum

Erratum to: Fluorescent glycan nanoparticle-based FACS assays for the identification of genuine drug-resistant cancer cells with differentiation potential

Chenglong Wang1,2, Wencai Guan2, Rong Chen3,4, Yael Levi-Kalisman5, Yichun Xu6, Liwen Zhang6, Min Zhou3,4(), Guoxiong Xu2(), Hongjing Dou1()
The State Key Laboratory of Metal Matrix Composites, School of Materials Science and Engineering, Shanghai Jiao Tong University, Shanghai 200240, China
Research Center for Clinical Research, Jinshan Hospital, Fudan University, Shanghai 200540, China
Department of Respiratory and Critical Care Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China
Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China
The Center for Nanoscience and Nanotechnology and the Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem 91905, Israel
Shanghai Biochip Co. Ltd. and National Engineering Center for Biochip at Shanghai, Shanghai 201203, China
Show Author Information
The online version of the original article can be found at:
https://doi.org/10.1007/s12274-020-2981-8

Keywords

glycan nanoparticleFACS assaysdrug resistancetumor heterogeneitydiagnose
Nano Research
Volume 14 Issue 11,
November 2021
Pages 4364-4364
DOI: 10.1007/s12274-021-3672-9
Cite this article:
Wang C, Guan W, Chen R, et al. Erratum to: Fluorescent glycan nanoparticle-based FACS assays for the identification of genuine drug-resistant cancer cells with differentiation potential. Nano Research, 2021, 14(11): 4364. https://doi.org/10.1007/s12274-021-3672-9
Metrics & Citations  
Article History
Copyright
Return